Clinical Trial Update: Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether chlorpheniramine prevents allergic transfusion reactions compared with placebo; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Transfusion Reaction

Drugs mentioned

• Chlorpheniramine (chlorpheniramine)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Allergic Transfusion Reaction | Phase 2 | Status: RECRUITING